Radiolabeled oligonucleotides targeting the RNA subunit of telomerase inhibit telomerase and induce DNA damage in telomerase-positive cancer cells
Telomerase is expressed in the majority (>85%) of tumours, but has restricted expression in normal tissues. Long-term telomerase inhibition in malignant cells results in progressive telomere shortening and reduction in cell proliferation. Here we report the synthesis and characterisation of r...
Main Authors: | Jackson, MR, Bavelaar, BM, Waghorn, PA, Gill, MA, El-Sagheer, AH, Brown, T, Tarsounas, M, Vallis, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Association for Cancer Research
2019
|
Similar Items
-
Targeting telomerase with radiolabeled inhibitors.
by: Waghorn, P, et al.
Published: (2016) -
Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides
by: Bavelaar, BM, et al.
Published: (2021) -
Mitochondria, Telomeres and Telomerase Subunits
by: Qian Zheng, et al.
Published: (2019-11-01) -
Telomerase-targeting radiopharmaceuticals for the selective treatment of cancer
by: Bavelaar, B
Published: (2018) -
An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity
by: Xiaoming Yi, et al.
Published: (2000-09-01)